Skip to main content
. Author manuscript; available in PMC: 2015 Mar 18.
Published in final edited form as: Cardiovasc Drugs Ther. 2013 Dec;27(6):499–510. doi: 10.1007/s10557-013-6487-4

Fig. 5.

Fig. 5

Change in absorbance at 540 nm, an index of LV mitochondrial swelling, following addition of 100 nmol Ca2+/mg mitochondrial protein. *P <0.05 for the DHA treated heart failure group compared to untreated heart failure; ^ P <0.05 for untreated sham compared to untreated heart failure. Groups sizes were 15 and 20 for the untreated sham and heart failure groups, respectfully, and 14 and 20 for the DHA treated sham and heart failure groups, respectfully